SciELO - Scientific Electronic Library Online

 
vol.32 issue11Reliability and validity of the Brazilian version of the Hospital Survey on Patient Safety Culture (HSOPSC): a pilot studyPerceived neighborhood characteristics and the functional performance of elderly people in the Belo Horizonte Metropolitan Area, Minas Gerais State, Brazil: a quantile regression analysis author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Cadernos de Saúde Pública

On-line version ISSN 1678-4464

Abstract

SCOPEL, Carolinne Thays  and  CHAVES, Gabriela Costa. Initiatives to challenge patent barriers and their relationship with the price of medicines procured by the Brazilian Unified National Health System. Cad. Saúde Pública [online]. 2016, vol.32, n.11, e00113815.  Epub Dec 01, 2016. ISSN 1678-4464.  http://dx.doi.org/10.1590/0102-311x00113815.

Since 1996, when antiretroviral (ARV) treatments started being guaranteed to people living with HIV in Brazil, the government has faced the challenge of ensuring sustainability of this policy within a context of incorporating patented medicines. This article sought to analyze the historical series of the price of lopinavir/ritonavir (LPV/r) in Brazil and in the international market also considering the initiatives to challenge patent barriers between 2001 and 2012. The methods used were mapping initiatives to challenge LPV/r patent barriers and the analysis of historical series of its price in Brazil and in the international market. Results show that, between 2001 and 2003, there were efforts to use compulsory licensing as a threat. From 2005 to 2007, initiatives by different satkeholders were identified: declaration of public interest, pre-grant opposition ("support to examination") and civil action. From 2006 to 2008, compulsory licensing initiatives in other countries resulted in a price reduction in Brazil. Between 2009 and 2012, there was a 30% reduction in the Brazilian purchasing price.

Keywords : Intellectual Property of Pharmaceutic Products and Process; Drug Price; Anti-Retroviral Agents.

        · abstract in Portuguese | Spanish     · text in English | Portuguese     · English ( pdf ) | Portuguese ( pdf )